--- title: 'Life Sciences Daily Summary: What Happened on October 29, 2026' headline: UK budget sets out £1 billion biopharma investment package description: BioSpace counted 4,062 employees affected by manufacturing cuts at 10 biopharma companies through October 28. url: https://thebench.bio/news/summaries/2026-10-29 topic: all date: '2026-10-29' covers: - '2026-10-29' date_published: '2026-10-29T12:05:41Z' date_modified: '2026-10-29T12:05:41Z' tags: - Funding - Manufacturing sources: 2 publisher: TheBench.Bio --- # Life Sciences Daily Summary: What Happened on October 29, 2026 **UK budget sets out £1 billion biopharma investment package** BioSpace counted 4,062 employees affected by manufacturing cuts at 10 biopharma companies through October 28. ## Today in brief The UK budget sets aside £1 billion for biopharma investment. [1] BioSpace counted 4,062 employees affected by manufacturing-site cuts across 10 companies, completed or projected through October 28. [2] ## Manufacturing cuts affect 4,062 jobs across 10 biopharma companies BioSpace counted 4,062 employees affected by completed or planned manufacturing-site cuts at 10 biopharma companies through October 28. [2] BioNTech accounts for the largest projected share, with 1,860 positions affected by planned site exits. [2] BioNTech plans to close its Idar-Oberstein and Marburg facilities by the end of 2027, and its Singapore site in the first quarter of 2027. [2] It also plans to exit CureVac sites in Germany and elsewhere by the end of 2027, following its all-stock acquisition of CureVac last year. [2] Five of the 10 companies had announced manufacturing investments of at least $1 billion in the prior three years. [2] Industry consultant Caitlin Prendes said companies can reduce staff at older facilities while investing in new domestic sites, including before those sites hire workers. [2] Eric Langer said manufacturing layoffs could continue in 2027 as companies focus more on productivity and costs. [2] ## The day in numbers - **£1 billion**: Value of the biopharma investment package included in the UK budget. [1] - **4,062**: Employees affected by completed or projected manufacturing-site cuts at 10 biopharma companies through October 28. [2] - **1,860**: Positions BioNTech expects to be affected by planned manufacturing-site exits. [2] ## Sources 1. [UK budget includes £1bn biopharma investment package](), pharmaphorum, 2026-10-29 2. [Biopharma cuts at manufacturing plants expected to affect 4,000+](), BioSpace, 2026-10-29 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: